NCT02686281View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes

PHASE1TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

April 30, 2014

Conditions
Healthy
Interventions
DRUG

GMC-252-L-Lysine

OTHER

Placebo

Trial Locations (1)

CF48 4DR

Simbec Research Ltd, Merthyr Tydfil

Sponsors
All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

lead

Genmedica Therapeutics S.L.

INDUSTRY